Bio-Techne (TECH) Competitors $49.63 -0.72 (-1.43%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$49.66 +0.03 (+0.06%) As of 07:55 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TECH vs. A, MTD, WAT, ILMN, BIO, BRKR, CRL, PACB, HBIO, and TMOShould you be buying Bio-Techne stock or one of its competitors? The main competitors of Bio-Techne include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Rad Laboratories (BIO), Bruker (BRKR), Charles River Laboratories International (CRL), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Bio-Techne vs. Agilent Technologies Mettler-Toledo International Waters Illumina Bio-Rad Laboratories Bruker Charles River Laboratories International Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies (NYSE:A) and Bio-Techne (NASDAQ:TECH) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations, community ranking, media sentiment and dividends. Which has higher earnings & valuation, A or TECH? Agilent Technologies has higher revenue and earnings than Bio-Techne. Agilent Technologies is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgilent Technologies$6.51B4.66$1.29B$4.3524.47Bio-Techne$1.20B6.56$168.10M$0.9950.13 Is A or TECH more profitable? Agilent Technologies has a net margin of 19.27% compared to Bio-Techne's net margin of 13.22%. Agilent Technologies' return on equity of 25.56% beat Bio-Techne's return on equity.Company Net Margins Return on Equity Return on Assets Agilent Technologies19.27% 25.56% 13.47% Bio-Techne 13.22%12.73%9.75% Does the MarketBeat Community believe in A or TECH? Agilent Technologies received 467 more outperform votes than Bio-Techne when rated by MarketBeat users. Likewise, 71.01% of users gave Agilent Technologies an outperform vote while only 62.31% of users gave Bio-Techne an outperform vote. CompanyUnderperformOutperformAgilent TechnologiesOutperform Votes86771.01% Underperform Votes35428.99% Bio-TechneOutperform Votes40062.31% Underperform Votes24237.69% Does the media favor A or TECH? In the previous week, Agilent Technologies had 9 more articles in the media than Bio-Techne. MarketBeat recorded 22 mentions for Agilent Technologies and 13 mentions for Bio-Techne. Agilent Technologies' average media sentiment score of 1.36 beat Bio-Techne's score of 1.34 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 17 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Bio-Techne 9 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer A or TECH? Agilent Technologies currently has a consensus price target of $143.00, suggesting a potential upside of 34.32%. Bio-Techne has a consensus price target of $81.14, suggesting a potential upside of 63.50%. Given Bio-Techne's higher probable upside, analysts clearly believe Bio-Techne is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilent Technologies 0 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.46Bio-Techne 0 Sell rating(s) 5 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.38 Do institutionals and insiders have more ownership in A or TECH? 98.9% of Bio-Techne shares are held by institutional investors. 3.9% of Bio-Techne shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, A or TECH? Agilent Technologies has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Comparatively, Bio-Techne has a beta of 1.45, suggesting that its share price is 45% more volatile than the S&P 500. Is A or TECH a better dividend stock? Agilent Technologies pays an annual dividend of $0.99 per share and has a dividend yield of 0.9%. Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.6%. Agilent Technologies pays out 22.8% of its earnings in the form of a dividend. Bio-Techne pays out 32.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies is clearly the better dividend stock, given its higher yield and lower payout ratio. SummaryAgilent Technologies beats Bio-Techne on 14 of the 20 factors compared between the two stocks. Get Bio-Techne News Delivered to You Automatically Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TECH vs. The Competition Export to ExcelMetricBio-TechneBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.85B$2.95B$5.54B$7.93BDividend Yield0.64%1.89%5.09%4.23%P/E Ratio50.1330.0722.5718.54Price / Sales6.56494.82399.89103.29Price / Cash28.30168.6838.1834.62Price / Book3.773.176.774.25Net Income$168.10M-$72.35M$3.22B$248.18M7 Day Performance-1.21%2.14%1.07%0.91%1 Month Performance-14.99%5.67%2.46%2.58%1 Year Performance-34.35%-23.57%15.74%4.02% Bio-Techne Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TECHBio-Techne4.8815 of 5 stars$49.63-1.4%$81.14+63.5%-32.4%$7.85B$1.20B50.133,000Upcoming EarningsPositive NewsAAgilent Technologies4.7283 of 5 stars$106.99+0.7%$143.00+33.7%-23.2%$30.50B$6.51B24.6017,900Positive NewsMTDMettler-Toledo International3.7202 of 5 stars$1,061.95+0.0%$1,304.25+22.8%-15.7%$22.13B$3.87B26.2018,000Earnings ReportShort Interest ↑Positive NewsWATWaters3.974 of 5 stars$340.10+0.7%$392.13+15.3%+8.1%$20.23B$2.96B31.768,200Upcoming EarningsILMNIllumina4.6949 of 5 stars$77.22-0.2%$138.70+79.6%-38.6%$12.22B$4.37B-10.0511,500Upcoming EarningsAnalyst ForecastPositive NewsBIOBio-Rad Laboratories4.4099 of 5 stars$240.50-0.9%$380.20+58.1%-12.2%$6.74B$2.57B-3.708,200Earnings ReportShort Interest ↑News CoveragePositive NewsBRKRBruker4.983 of 5 stars$39.66+1.5%$65.00+63.9%-50.2%$6.01B$3.37B52.188,520Upcoming EarningsShort Interest ↓Positive NewsCRLCharles River Laboratories International4.8185 of 5 stars$115.16+0.4%$182.00+58.0%-49.8%$5.66B$4.05B767.7321,400Upcoming EarningsPACBPacific Biosciences of California3.3021 of 5 stars$1.13+3.7%$2.45+116.8%-34.3%$336.57M$154.01M-0.69730Upcoming EarningsNews CoverageHBIOHarvard Bioscience3.9465 of 5 stars$0.38+1.5%$4.50+1,076.5%-91.1%$16.91M$94.14M-1.16490Upcoming EarningsGap UpTMOThermo Fisher Scientific4.8524 of 5 stars$421.55-0.6%$616.95+46.4%-27.0%$159.13B$42.90B25.50130,000Analyst ForecastInsider TradeShort Interest ↑ Related Companies and Tools Related Companies A Competitors MTD Competitors WAT Competitors ILMN Competitors BIO Competitors BRKR Competitors CRL Competitors PACB Competitors HBIO Competitors TMO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TECH) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Techne Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Techne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TECH Stock Free TECH Stock Alerts